These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25435003)

  • 1. Analytics for vaccine economics and pricing: insights and observations.
    Robbins MJ; Jacobson SH
    Expert Rev Vaccines; 2015 Apr; 14(4):605-16. PubMed ID: 25435003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms.
    Jacobson SH; Sewell EC; Allwine DA; Medina EA; Weniger BG
    Expert Rev Vaccines; 2003 Feb; 2(1):15-9. PubMed ID: 12901593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm.
    Jacobson SH; Karnani T; Sewell EC
    Vaccine; 2004 Jun; 22(17-18):2307-15. PubMed ID: 15149790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiered pricing of vaccines: a win-win-win situation, not a subsidy.
    Plahte J
    Lancet Infect Dis; 2005 Jan; 5(1):58-63. PubMed ID: 15620562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between pharmaceutical industry and public health in vaccination].
    Gervasi G; Capanna A; Soncini R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2015; 71(2):225-32. PubMed ID: 26057178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study.
    Jacobson SH; Sewell EC; Deuson R; Weniger BG
    Health Care Manag Sci; 1999 Jan; 2(1):1-9. PubMed ID: 10916597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approved but non-funded vaccines: accessing individual protection.
    Scheifele DW; Ward BJ; Halperin SA; McNeil SA; Crowcroft NS; Bjornson G
    Vaccine; 2014 Feb; 32(7):766-70. PubMed ID: 24374500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic aspects of vaccines and immunizations.
    Hinman AR
    C R Acad Sci III; 1999 Nov; 322(11):989-94. PubMed ID: 10646095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary.
    Behzad B; Jacobson SH; Sewell EC
    Expert Rev Vaccines; 2012 Oct; 11(10):1189-97. PubMed ID: 23176652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.